The natural history of hypertrophic cardiomyopathy;Historia natural de la miocardiopatía hipertrófica

Revista Espanola de Cardiologia

Volumn 49, Issue 3, 1996, Pages 214-225

  De La Calzada, Carlos Sáenz ^a   De Meneses, Rocío Tello ^b   Delgado Jiménez, Juan ^a   Gómez Pajuelo, Casimiro ^a   Gómez Sánchez, Miguel Ángel ^a   González Cocina, Emilio ^c  

^a HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^b HOSPITAL UNIVERSITARIO PRÍNCIPE DE ASTURIAS   (Spain)

^c HOSPITAL COSTA DEL SOL   (Spain)

Author keywords

Hypertrophic cardiomyopathy; Natural history

Indexed keywords

ADOLESCENT; ADULT; AGED; CHILD; COMPARATIVE STUDY; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; GENETICS; HEART ARRHYTHMIA; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE ISCHEMIA; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; MIDDLE AGED; MUTATION; NEWBORN; PATHOPHYSIOLOGY; PRESCHOOL CHILD; PROGNOSIS; REVIEW; RISK FACTOR; SUDDEN DEATH;

ADOLESCENT; ADULT; AGED; ARRHYTHMIA; CARDIOMYOPATHY, HYPERTROPHIC; CHILD; CHILD, PRESCHOOL; DEATH, SUDDEN; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; HUMANS; INFANT, NEWBORN; MIDDLE AGED; MUTATION; MYOCARDIAL ISCHEMIA; PROGNOSIS; RISK FACTORS; VENTRICULAR DYSFUNCTION, LEFT;

EID: 0030100191     PISSN: 03008932     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (86)

1. Brock R. Functional obstruction of the left ventricle (acquired aortic subvalvular stenosis). Guy's Hosp Rev 1957; 106: 221-238.
2. Teare D. Asimmetrical hypertrophy of the heart in young adults. Br Heart J 1958; 20: 1-8.
3. Frank S, Braunwald E. Idiopathic hypertrophic subaortic stenosis; clinical analysis of 126 patients with emphasis on the natural history. Circulation 1968; 37: 759-788.
4. Hardarson T. De la Calzada CS, Curiel R, Goodwin JF. Prognosis and mortality of hypertrophic obstructive cardiomyopathy. Lancet 1973; 2: 1.462-1.467.
5. Shah PM, Adelman AG, Wigle ED, Gobel FL, Burchel HB, Hardarson T et al. The natural (and unnatural) hystory of hypertrophic obstructive cardiomyopathy. Circ Res 1973; 34 (Supl 2): 179-195.
6. Cleland VP. The surgical management of obstructive cardromyopathy. J Cardiovasc Surg 1963; 4: 489-491.
7. Wigle ED, Sasson Z, Henderson MA. Hypertrophic cardiomyopathy: the importance of site and extent of hypertrophy. A review Prog Cardiovasc Dis 1985; 28: 1-83.
8. Davies MJ, Pomerance A, Teare RD. Pathological features of hypertrophic obstructive cardiomyopathy. J Clin Pathol 1974; 27: 529-535.
9. McKenna WJ, England D, Doi YL, Deanfield JE, Oakley CM, Goodwin JF. Arrhythmias in hypertrophic cardiomyopathy. I. Influence on prognosis. Br Heart J 1981; 46: 168-172.
10. Maron BJ, Bonow RO, Cannon RO, Leon MD, Epstein SE. Hypertrophic cardiomyopathy: interrelations of clinical manifestations, pathophysiology and therapy. N Engl J Med 1987; 316: 780-789.
11. Mckenna WJ, Stewart JT, Nihoyannopoulos P, McGinty F, Davies MJ. Hypertrophic cardiomyopathy without hypertrophy: two families with myocardial disarray in the absence of increased myocardial mass. Br Heart J 1990; 63: 287-290.
12. Maron BJ, Kragel AH, Roberts WC. Sudden death in hypertrophic cardiomyopathy with normal left ventricular mass. Br Heart J 1990; 63: 308-310.
13. Solomon SD, Jarcho JA, McKenna W, Geisterfer-Lowrance A, Germain R, Salerni R et al. Familial Hypertrophic cardiomyopathy is a genetically heterogeneous disease. J Clin Invest 1990; 86: 993-999.
14. Hassenstein P, Storch HH, Schmitz W. Erfahrungen mit der Schrittmacher dauerbehandlung bei patient mit obstruktiver kardiomyopathie. Thoraxchirurgie 1975; 23: 496-498.
15. Tascón JC, Albarrán A, Andreu J, Alonso M. El tratamiento quirúrgico precoz de la miocardiopatía hipertrófica obstructiva sintomática. Argumentos en contra. Rev Esp Cardiol 1995; 48: 229-234.
16. Wigle ED, Sasson Z, Henderson MA, Ruddy TD, Fulop J, Rakowski H et al. Hypertrophy cardiomyopathy. The importance of the site and extent of hypertrophy. A review. Prog Cardiovasc Dis 1985; 28: 1-83.
17. Maron BJ, Gottdiener JS, Epstein SE. Patterns and significance of distribution of left ventricular hypertrophy in hypertrophic cardiomyopathy. Am J Cardiol 1981; 48: 418-428.
18. Shapiro LM, McKenna WJ. Distribution of left ventricular hypertrophy in hypertrophic cardiomyopathy: a two-dimensional echocardiographic study. J Am Coll Cardiol 1983; 2: 437-444.
19. Spirito P, Maron BJ. Relation between extent of left ventricular hypertrophy and occurrence of sudden cardiac death in hypertrophic cardiomyopathy. J Am Coll Cardiol 1990; 15: 1.521-1.526.
20. Dritsas A, Gilligan D, Sbarouni E, Oakley CM. Nihoyannopoulos P. Influence of left ventricular hypertrophy and function on the occurrence of ventricular tachycardia in hypertrophic cardiomyopathy. Am J Cardiol 1992; 70: 913-916.
21. Webb JG, Sasson Z, Rakowski H, Lin P, Wigle ED. Apical hypertrophic cardiomyopathy: clinical follow-up and diagnostic correlates. J Am Coll Cardiol 1990; 15: 83-90.
22. Alfonso F, Nihoyannopoulos P, Stewart J et al. Clinical significance of giant negative T waves in hypertrophic cardiomyopathy. J Am Coll Cardiol 1990; 15: 965-971.
23. McKenna WJ, Kleinebenne A, Nihoyannopoulos P, Foale R Echocardiographic measurements of right ventricular wall thickness in hypertrophic cardiomyopathy: relation to clinical and prognostic features. J Am Coll Cardiol 1988; 11: 351-358.
24. Lewis JF, Maron BJ. Hypertrophic cardiomyopathy characterized by marked hypertrophy of the posterior left ventricular free wall: significance and clinical implications. J Am Coll Cardiol 1991; 18: 421-428.
25. Maron BJ, Spirito T, Wesley Y, Arce J. Development or progression of left ventricular hypertrophy in children with hypertrophic cardiomyopathy: identification by two dimensional echocardiogiaphy. N Engl J Med 1986; 315: 610-614.
26. Maron BJ. Cardiomyopathies. En: Adams FH, Emmanoulides GC, Reimenschneider TA, editores. Moss' Heart disease in infants, children and adolescents. Baltimore: William and Wilkins. 1989; 47: 940-964.
27. Panza JA, Maris TJ, Maron BJ. Development and determinants of dynamic obstruction to left ventricular outflow in young patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 1989; 13: 820-823.
28. Spirito P, Maron BJ. Absence of progression of left ventricular hypertrophy in adults patients with hypertrophic cardiomyopathy. Am J Cardiol 1987; 9: 1.013-1.017.
29. Spirito P, Maron BJ, Bonow RO, Epstein SE. Occurrence and significance of progressive left ventricular wall thinning and relative cavity dilatation in hypertrophic cardiomyopathy. Am J Cardiol 1987; 60: 123-129.
30. Spirito P, Maron BJ. Relation between extent to left ventricular hypertrophy and age in hypertrophic cardiomyopathy. J Am Coll Cardiol 1989; 13: 820-823.
31. McKenna W, Deanfield J, Faruqui A, England D, Oakley CM, Goodwin JF. Prognosis in hypertrophic cardiomyopathy: role of age and clinical electrocardiographic and hemodynamic features. Am J Cardiol 1981; 47: 532-538.
32. Schwammenthal E, Schvartzkopff B, Block M, Johns J, Lose B, Engberding R et al. Doppler echocardiographic assessment of the pressure gradient during bycicle ergometry in hypertrophic cardiomyopathy. Am J Cardiol 1992; 69: 1.623-1.628.
33. Maron BJ, Bonow RO, Cannon RO, Leon MD, Epstein SE. Hypertrophic cardiomyopathy: interrelations of clinical manifestations, pathophysiology and therapy. N Engl J Med 1987; 316: 780-789.
34. Newman H, Sugrue DD, Oakley CM, Goodwin JF, McKenna WJ. Relation of left ventricular function and prognosis in hypertrophic cardiomyopathy: an angiographic study. J Am Coll Cardiol 1985; 5: 1.064-1.074.
35. Koffard MJ, Waldastein DJ, Vos J, Ten Cate FG. Prognosis in hypertrophic cardiomyopathy observed in a large clinic population. Am J Cardiol 1993; 72: 939-943.
36. Goodwin JF, Krikler DM, Arrhythmias as a cause of sudden death in hypertrophic cardiomyopathy. Lancet 1976; 2: 937-940.
37. McKenna WJ, Deanfield JE. Hypertrophic cardiomyopathy: an important cost of sudden death. Arch Dis Child 1984; 59: 971-975.
38. Savage DD, Seides SF, Maron BJ, Myers DM, Epstein SE. Prevalence of arrhythmias during 24-hour electrocardiographic monitoring and exercise testing in patients with obstructive and non obstructive hypertrophic cardiomyopathy. Circulation 1979; 59: 866-875.
39. Glandy DL, O'Brien KP, Gold HK. Atrial fibrillation in patients with hypertrophic subaortic stenosis. Br Heart J 1970; 32: 652-659.
40. Robinson K, Frenneaux MP, Stockins B, Karatasakis G, Poloniecki JD, McKenna WJ. Atrial fibrillation in hypertrophic cardiomyopathy: a longitudinal study. J Am Coll Cardiol 1990; 15: 1.279-1.285.
41. Krikler DM, Davies MJ, Rowland E, Goodwin JF, Evans RC, Shaw DB. Sudden death in hyperytrophic cardiomyopathy: associated accessory atrioventricular pathways. Br Heart J 1980; 43: 245-251.
42. Fananapazir L, Tracy CM, Leon MB, Winkler JB, Cannon RO, Bonow RO et al. Electrophysiologic abnormalities in patients with hypertrophic cardiomyopathy. A consecutive analysis of 155 patients. Circulation 1989; 80: 1.259-1.268.
43. Geibel A, Brugada P, Zehender M, Stevenson W, Waldecker B, Wellens HJJ. Value of programmed electrical stimulation using an standardized ventricular stimulation protocol in hypertrophic cardiomyopathy. Am J Cardiol 1987; 60: 738-739.
44. McKenna WJ, Alfonso F. Arrhythmias in the cardiomyopathies and mitral valve prolapse. En: Zipes D, Rowlands D, editores. Progress in cardiology. Filadelfia: Lea & Febiger, 1988; 59-75.
45. Maron BJ, Savage DD, Wolfson JK, Epstein SE. Prognostic significance of 24-hour ambulatory electrocardiographic monitoring in patients with hypertrophic cardiomyopathy: prospective study. Am J Cardiol 1981; 48: 252-257.
46. Spirito P, Rapezzi C, Autore C, Bruzzi P, Bellone P, Ortolani P et al. Prognosis of asymptomatic patients with hypertrophic cardiomyopathy and non sustained ventricular tachycardia. Circulation 1994; 90: 2.743-2.747.
47. Fananapazir I, Chang AC, Epstein ND, McAreavey D. Prognostic determinants in hypertrophic cardiomyopathy: prospective evaluation of therapeutic strategy based on clinical, Holter, hemodinamic and electrophysiological findings. Circulation 1992; 86: 730-740.
48. Atiga WL, McAreavey D, Epstein ND, Fananapazir I. Risk stratification of asymptomatic patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 1994; 23: 110-116.
49. Saumarez RC, Camm AJ, Panagos A, Gill JS, Stewart JJ, DeBelder MA et al. Ventricular fibrillation in hypertrophic cardiomyopathy is associated with increased fractionation of paced right ventricular electrograms. Circulation 1992; 86: 467-447.
50. Saumarez RC, Slade AKB, Grace AA, Sadoul N, Camm AJ, McKenna WJ. The significance of paced electrogram fractionation in hypertrophic cardiomyopathy. A prospective study. Circulation 1995; 91: 2.762-2.768.
51. Sadoul N, Saumarez RC, McKenna WJ. Identification of high risk patients with hypertrophic cardiomyopathy. Cardiol Rev 1995; 3: 44-52.
52. Buja G, Miorelli M, Turrini P, Melacini P, Nava A. A comparison of QT dispersion in hypertrophic cardiomyopathy between patients with and without ventricular arrhythmia and sudden death. Am J Cardiol 1993; 72: 973-976.
53. Gilligan DM, Chang WL, Sbarouni E, Nihoyannopoulos P, Oakley CM. Autonomic function in hypertrophic cardiomyopathy. Br Heart J 1993; 69: 525-529.
54. O'Gara PT, Bonow RO, Maron BJ, Damske BA, Van Lingen A, Bacharach SL et al. Myocardial perfusion abnormalities in patients with hypertrophic cardiomyopathy. Assessment with thallium-201 emission computed tomography. Circulation 1987; 76: 1.214-1.223.
55. Maron BJ, Kogan J, Proschan MA, Hecht GM, Roberts WC. Circadian variability in the occurrence of sudden death in patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 1994; 23: 1.405-1.409.
56. Dilsizian V, Bonow RO, Epstein SE, Fananapazir I. Myocardial ischemia detected by thallium scintigraphy is frequently related to cardiac arrest and syncope in young patients with hypetrophic cardiomyopathy. J Am Coll Cardiol 1993; 22: 796-804.
57. Frenneaux MP, Counihan PJ, Caforio ALP, Chikamori T, McKenna WJ. Abnormal blood pressure response during exercise in hypertrophic cardiomyopathy. Circulation 1990; 82: 1.995-2.002.
58. Gilligan DM, Nihoyannopoulos P, Chang WL, Oakley CM. Investigation of hemodynamic basis for syncope in hypertrophic cardiomyopathy. Use of a head-up tilt test. Circulation 1992; 85: 2.140-2.148.
59. Mizumaki K, Fujiki A, Tani M, Shimono M, Hayashi H, Inoue H. Left ventricular dimensions and autonomic balance during head-up tilt differ between patients with isoproterenol-dependent and isoproterenol-independent neurally mediated syncope. J Am Coll Cardiol 1995; 26: 164-173.
60. Sneddon JF, Slade A, Seo H, Camm J, McKenna WJ. Assessment of the diagnostic value of head-up tilt testing in the evaluation of syncope in hypertrophic cardiomyopathy. Am J Cardiol 1994; 15: 601-604.
61. Watkins H. Multiple disease genes cause hypertrophic cardiomyopathy. Br Heart J 1994; 72 (Supl): 4-9.
62. Watkins H, McKenna WJ, Thirfelder L, Suck HJ, Anan R, O' Donoghue A et al. Mutations in the genes for cardiac troponin T and alfa tropomiosin in hypetrophic cardiomyopathy. N Engl J Med 1995; 332: 1.058-1.064.
63. Watkins H, Thierfelder L, Hwang DS, McKenna WJ, Seidman JG, Seidman CE. Sporadic hypertrophic cardiomyopathy due to de novo myosin mutations. J Clin Invest 1992; 90: 1.666-1.671.
64. Watkins H, Rosenzweing A, Hwang DS, Levi T, Mckenna WJ, Seidman CE et al. Characteristics and prognostic implications of myosin missense mutations in familial hypertrophic cardiomyopathy. N Engl J Med 1992; 326: 1.108-1.114.
65. Rosenzweig A, Watkins H, Hwang D, Miri M, McKenna WJ, Traill TA et al. Preclinical diagnosis of familial hypertrophic cardiomyopathy by genetic analysis of blood lymphocytes. N Engl J Med 1991; 325: 1.753-1.760.
66. Epstein ND, Cohn GM, Cyran F, Fananapazir I. Differences in clinical expression of hypertrophic cardiomyopathy associated with two distinct mutations in the beta-myosin heavy chain gene. A 908Leu→Val mutation and a 403-Arg-→Gln mutation. Circulation 1992; 86: 345-352.
67. Maron BJ, Lipson LC, Roberts WC, Savage DD, Epstein SE. ≪Malignant≫ hypertrophic cardiomyopathy: identification of a subgroup of families with an unusually frequent premature death. Am J Cardiol 1978; 41: 1.133-1.140.
68. Maron BJ, Fananazapir I. Sudden cardiac death in hypertrophic cardiomyopathy. Circulation 1992; 85 (Supl 1): 57-63.
69. Sáenz de la Calzada C, Gómez Pajuelo C, Casinello C, Tello R, García Pascual, Puigoneta B et al. Miocardiopatía hipertrófica en el viejo: estudio clínico de 30 casos. Rev Esp Geriatr Gerontol 1991; 26: 369-372.
70. Lewis J, Maron BJ. Clinical and morphologic expression of hypertrophic cardiomyopathy in patients > 65 years of age. Am J Cardiol 1994; 73: 1.105-1.111.
71. Sáenz de la Calzada C, Castro C, Fernández de Tejada A, Cosío FG, Moro C. La miocardiopatía hipertrófica en el viejo. Rev Clin Esp 1978; 150: 103.
72. Fay WP, Taliercio CP, Ilstrup DM, Tajik AJ, Gersh BJ. Natural history of hypertrophic cardiomyopathy in the elderly. J Am Coll Cardiol 1990; 16: 821-826.
73. Lever HM, Karam RF, Currie PJ, Healy BP. Hypertrophic cardiomyopathy in the elderly: distinction from the young based on cardiac shape. Circulation 1989; 79: 580-589.
74. Lewis JF, Maron BJ. Elderly patients with hypertrophic cardiomyopathy: a subset with distinctive left ventricular morfology and progressive clinical course late in life. J Am Coll Cardiol 1989; 13: 36-45.
75. Maron BJ, Tajik AJ, Ruttemberg HD. Hypertrophic cardiomyopathy in infants. Clin Circ 1982; 65: 7-17.
76. McKenna WJ, Franklin RCG, Nihoyannopoulos P, Robinson KC, Deanfield JE. Arrhythmia and prognosis in infants, children and adolescents with hypertrophic cardiomiopathy. J Am Coll Cardiol 1988; 11: 147-153.
77. Aron LA, Hertzeanu HL, Fisman EZ, Nosrati IS, Kellennan JJ. Prognosis of non obstructive hypertrophic cardiomyopathy. Am J Cardiol 1991; 67: 215-217.
78. Sakamoto T, Tei C, Murayama M, Ichiyasu H, Hada Y. Giant T wave inversion as a manifestation of asymmetrical apical hypertrophy of the left ventricle: echocardiographic and ultrasono-cardiotomographic study. Jpn Heart J 1976; 17: 611-629.
79. Penas M, Fuster M, Fabregas R, Llorente C, Cosío FG. Familial apical hypertrophic cardiomyopathy. Am J Cardiol 1988; 62: 821-822.
80. Webb JG, Sasson Z, Rakowski H, Liu P, Wigle ED. Apical hypertrophic cardiomyopathy: clinical follow-up and diagnostic correlates. J Am Coll Cardiol 1990; 15: 83-90.
81. Maron BJ, Bonow RO, Sashagiri TN, Roberts WC, Epstein SE. Hypertrophic cardiomyopathy with ventricular septal hypertrophy localized to the apical region of the left ventricle (apical hypertrophic cardiomyopathy). Am J Cardiol 1982; 49: 1.838-1.848.
82. Maron BJ, Klues HG. Surviving competitive athletics with hypertrophic cardiomyopathy. Am J Cardiol 1994; 73: 1.098-1.104.
83. Maron BJ, Epstein SE, Roberts WC. Causes of sudden death in competitive athletes. J Am Coll Cardiol 1986; 7: 204-214.
84. Burke AP, Farb A, Virmani R, Goodin J, Smialek JE. Sports-related and non-sport-related sudden cardiac death in young adults. Am Heart J 1991; 121: 568-575.
85. Spirito P, Chiarella F, Carrantino L, Berisso MZ, Bellotti P, Vecchio C. Clinical course and prognosis of hypertrophic cardiomyopathy in an outpatient population. N Engl J Med 1989; 320: 749-755.
86. Abelmann WH, Lorell BH. The challenge of cardiomiopathy. J Am Coll Cardiol 1989; 13: 1.219-1.239.